Purine Content
LevelMedium Risk Purine level: moderate (category estimate)
Sourcescientific_consensus category_estimate
Frequently Asked Questions
What are the purine levels in Restaurant Latino Tamale Pork?
While exact purine measurements for Restaurant Latino Tamale Pork are limited, it is classified as None for gout. This assessment is grounded in consensus from the research literature and category-level data. Consult our full review for dietary recommendations.
Is Restaurant Latino Tamale Pork high in fructose?
Restaurant Latino Tamale Pork contains about 0.2g of fructose per 100g, which is a moderate amount. The liver converts fructose in a way that accelerates purine breakdown and raises uric acid. Not excessive on its own, yet it adds to the fructose load across your day.
Can I eat Restaurant Latino Tamale Pork with gout?
Restaurant Latino Tamale Pork is generally safe for people with gout. may contain moderate purines. Under 50 mg of purines per 100g is the level most gout guidelines regard as low-risk. As part of an overall balanced approach it can be included, but personal medical advice takes priority.
What food category does Restaurant Latino Tamale Pork belong to?
Restaurant Latino Tamale Pork is classified under Meat in our gout food database. Its category placement gives helpful framing when comparing foods in your gout diet. Browse other meat items to compare purine and fructose levels across similar foods.
What are other gout-safe foods like Restaurant Latino Tamale Pork?
If you enjoy Restaurant Latino Tamale Pork, you may also want to explore other meat items rated SAFE for gout in our database. Within that group, prioritize items with purine below 50 mg/100g and fructose below 2g/100g. Browse our meat category page for full comparisons.
Data Quality
This entry uses T2-level data:
At least one dimension is directly measured; the other is based on scientific consensus.
Sources include USDA FoodData Central (public domain, CC0 1.0), the USDA+ODS-NIH Database for the Purine Content of Foods Release 2.0 (2025), Kaneko et al. Biol Pharm Bull 2014, and ACR/EULAR clinical guidelines.